Imaging in Interventions for Valvular Disease

In this interview, Alex Sticchi speaks with Fabien Praz and Michael Borger, co-chairs of the 2025 ESC/EACTS Valvular Guidelines Task Force. They discuss the major updates, including the central role of multimodality imaging, the lowered age threshold for TAVI, the distinction between atrial and ventricular secondary...

Alex Sticchi provides his take on the new ESC Valvular Guidelines presented at the ESC Congress 2025 in Madrid.

An 81-year-old patient with symptomatic severe aortic stenosis, a 74° horizontal aorta, and critically low coronary height—a challenging mix that pushed the heart team to weigh all procedural options. Discover how detailed CT analysis, intra-procedural strategy, and step-by-step imaging assessments guided their approach. What would you...

Mitral transcatheter edge-to-edge repair (M-TEER) has reshaped the prognosis for heart failure patients with secondary mitral regurgitation, but recurrence remains a real challenge when surgical options are off the table.

This case highlights an innovative use of an atrial flow regulator (AFR) to manage elevated left atrial...

What’s the safest approach when surgical options are off the table? This real-life case shows how complex coronary revascularsation and TAVI were performed in a single session, supported by Impella.

Explore the rationale behind the sequence, the device choices, and the outcome in a high-risk patient with...

An 82-year-old male patient with a history of PM (pacemaker) implantation in 2024, and ischaemic cardiomyopathy presented with symptomatic heart failure due to severe secondary mitral regurgitation and impaired LV function (EF 40 %). He also presented with recurrent gastro-intestinal bleeding while on DOAC for atrial...

Learn how 4D intracardiac echocardiography (ICE) is reshaping structural heart procedures. This EuroPCR 2025 session takes you through the latest in imaging technology—highlighting the benefits of 4D ICE and AI integration in improving the safety, precision, and efficiency of mitral and tricuspid interventions. From valve repair...

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...

A 70-year-old male patient presents with severe dyspnea (NYHA III) and marked leg edema, alongside a complex medical history including hypertrophic cardiomyopathy, pulmonary hypertension, and liver fibrosis.

With invasive hemodynamic measurements indicating elevated pressures and reduced cardiac output, how would you approach the treatment of this patient,...

The objective of this study was to validate standardised clinical criteria for BVD and evaluate its association with mortality and rehospitalisation, thereby guiding optimal valve selection in clinical practice.